Why Ireland's generic drug makers are the big winners in the Tariff War

The tariff-free EU-US arrangement will accelerate the trend towards generic drugs.
Why Ireland's generic drug makers are the big winners in the Tariff War

Generic drugs are now a major part of the pharmaceutical industry in Ireland, with the two largest global manufacturers, Teva Pharmaceutical and Sandoz Group, well established in Ireland.

On Thursday, the Trump Administration clarified the original deal on EU drugs exported to the US. The big news was not so much that the maximum tariff would be 15% on branded drugs when imported into the US from Europe, but the communication that generic drugs would be exempt from the 15% duty.

Generic drugs are now a major part of the pharmaceutical industry in Ireland, with the two largest global manufacturers, Teva Pharmaceutical and Sandoz Group, well established in Ireland. The exemption will enable these companies to expand their Irish operations and continue their exports to the US.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited